Determining the total amount of cholesterol within the bloodstream that isn’t carried by high-density lipoprotein (HDL) provides a valuable metric for assessing cardiovascular risk. This value is derived by subtracting the HDL cholesterol level from the total cholesterol level. For example, if an individual’s total cholesterol is 200 mg/dL and their HDL cholesterol is 50 mg/dL, the resulting value is 150 mg/dL.
This calculation offers a more comprehensive assessment than simply looking at LDL (low-density lipoprotein) cholesterol alone, as it encompasses all atherogenic lipoproteins. Identifying elevated levels is particularly useful for individuals with diabetes, metabolic syndrome, or high triglycerides, where LDL particle size may be small and dense, increasing cardiovascular risk, but not fully captured by standard LDL cholesterol measurements. Historically, this measurement has gained prominence as a readily available and cost-effective means to refine risk stratification.
